Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1993;88:1518-1526

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tousoulis, D.
Right arrow Articles by Maseri, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tousoulis, D.
Right arrow Articles by Maseri, A.

Circulation, Vol 88, 1518-1526, Copyright © 1993 by American Heart Association


ARTICLES

Coronary vasomotor effects of serotonin in patients with angina. Relation to coronary stenosis morphology

D Tousoulis, G Davies, E McFadden, J Clarke, JC Kaski and A Maseri
Cardiovascular Research Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.

BACKGROUND. Previous experimental studies have shown that the effect of serotonin on a coronary stenosis depends on whether that stenosis is compliant or fixed. However, the relation between coronary stenosis morphology and the response to serotonin in patients with angina is not known. METHODS AND RESULTS. Using computerized quantitative coronary angiography, we studied the effects of intracoronary infusion of serotonin on 38 coronary stenoses of different morphologies (concentric, eccentric, complicated) in 11 patients with stable angina and 4 with variant angina. In response to the maximum infused concentration of serotonin, 100% of complicated stenoses and 50% of concentric stenoses constricted by > or = 20% (P < .05). The magnitude of constriction was greater at eccentric stenoses (32.08 +/- 4.1%) than concentric stenoses (15.68 +/- 2.8%, P < .05) and greater in complicated stenoses (57.69 +/- 7.6%, P < .05) than eccentric stenoses. At complicated stenoses, the constriction was greater (0.85 +/- 0.16 mm, P < .05) than at the adjacent reference segments (0.42 +/- 0.12 mm). It was similar to the reference segment for both concentric and eccentric stenoses. The constriction at the stenosis was greater for irregular (complicated) lesions than for smooth (concentric and eccentric) lesions in both patients with stable (51.8 +/- 7.3% versus 22.5 +/- 4.1%, P < .001) and those with variant (77 +/- 17% versus 28.2 +/- 8.1%, P < .05) angina. There was a weak correlation (r = .39) of magnitude of constriction with stenosis length but not with baseline stenosis severity (minimum diameter). CONCLUSIONS. In these patients, the magnitude of the vasoconstrictor response to serotonin at the site of an atheromatous coronary plaque depends on the morphological characteristics of the plaque and is more closely related to irregular contour than stenosis severity or length. This relation suggests that variations in receptor type or density or in the smooth muscle cell response to stimulation may determine the response to locally released serotonin in patients with coronary disease.


This article has been cited by other articles:


Home page
CirculationHome page
D. Tousoulis, C. Pitsavos, C. Stefanadis, A. Tanaka, T. Sano, M. Namba, Y. Nishibori, Y. Nishida, T. Kawarabayashi, D. Fukuda, et al.
C-Reactive Protein and Lesion Morphology * Response
Circulation, March 9, 2004; 109 (9): e153 - e153.
[Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, G J Davies, C Tentolouris, T Crake, G Goumas, C Stefanadis, and P Toutouzas
Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries
Heart, May 1, 2003; 89(5): 531 - 534.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, G J Davies, T Crake, and P C Toutouzas
Vasomotion and nitric oxide bioactivity in diseased coronary arteries
Heart, April 1, 2002; 87(4): 320 - 321.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D.J Patel, A.H Gomma, C.J Knight, D.A Mulcahy, C.A Wright, H.J Purcell, and K.M Fox
Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina?. An observational study of myocardial ischaemia and its relation to coronary anatomy
Eur. Heart J., November 1, 2001; 22(21): 1991 - 1996.
[Abstract] [PDF]


Home page
HeartHome page
D Tousoulis, G J Davies, C Tentolouris, G Goumas, C Stefanadis, and P Toutouzas
Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque
Heart, September 1, 2001; 86(3): 296 - 301.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, C Tentolouris, T Crake, G Goumas, C Stefanadis, P Toutouzas, and G Davies
Complex stenosis morphology and vasomotor responses to inhibition of nitric oxide synthesis
Heart, November 1, 2000; 84(5): 529 - 534.
[Abstract] [Full Text]


Home page
HeartHome page
D Tousoulis, C Tentolouris, T Crake, C Stefanadis, P Toutouzas, and G Davies
Evidence of partially preserved endothelial dilator function in diseased coronary arteries
Heart, October 1, 1999; 82(4): 471 - 476.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, C Tentolouris, T Crake, G Katsimaglis, C Stefanadis, P Toutouzas, and G J Davies
Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P
Heart, May 1, 1999; 81(5): 505 - 511.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
C. Palmieri, M. P. R. Sicari, E. Picano, A. Biagini, and M. Marzilli
Quantitative Assessment of Coronary Atherosclerotic Plaque Profile by Morphometric Analysis of Angiographic Images
Angiology, November 1, 1996; 47(11): 1053 - 1059.
[Abstract] [PDF]